I am still holding my CTYX shares. $MILV . now known as $NDT Nano Delivery Technology Pharmaceuticals Inc, was called here in Dec last year, and has completed 99% of the process of saving a dead shell and R/M with a Billion dollar Biotech. Nevada SOS and OTC markets and TA share data is all current.
Every single thing on Oct 2019 Shareholder letter, Management to do list is done. Just one thing left, the restoration of SEC registration and reporting.
I expect a 40 Mil cash raise (at no lower that $4/share) and over night uplist to NYSE with an SEC 1-A filling in days to maybe 4 weeks max.
OS is 475K shares and float 290K shares. Float can not change for 12 months.
When the web site goes live, and the SEC S-1 or 1-A version of an S-1 drops and they uplist this can go to $100 to $300/share in months.
I expect a drink line challenge to Gatorade (sold through PepsiCo???)
The drink would be an Oral IV (no needle) that has food grade FDA GAS , Generally Accepted as Safe approved ingredients that can cross the Blood brain barrier (UPennMed has been testing it in NIH trials since 2016 in a JV deal with the Biotech R/M with NDTP. No FDA Drig trials needed.
$NDTP and the Firm (CCA, LLC) R/M with NDTP are the same person.
The stock has traded for 2-3 weeks now under the new ticker at an average of close to $4/share, the 200 day MA.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
